Ziats Mark N, Rennert Owen M
Laboratory of Clinical and Developmental Genomics, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA; Department of Physiology, Development and Neuroscience, University of CambridgeCambridgeshire, UK; Medical Scientist Training Program, Baylor College of MedicineHouston, TX, USA.
Laboratory of Clinical and Developmental Genomics, National Institute of Child Health and Human Development, National Institutes of Health , Bethesda, MD, USA.
Front Genet. 2016 Apr 26;7:65. doi: 10.3389/fgene.2016.00065. eCollection 2016.
The autism spectrum disorders (ASD) are a heterogeneous set of neurodevelopmental syndromes defined by impairments in verbal and non-verbal communication, restricted social interaction, and the presence of stereotyped patterns of behavior. The prevalence of ASD is rising, and the diagnostic criteria and clinical perspectives on the disorder continue to evolve in parallel. Although the majority of individuals with ASD will not have an identifiable genetic cause, almost 25% of cases have identifiable causative DNA variants. The rapidly improving ability to identify genetic mutations because of advances in next generation sequencing, coupled with previous epidemiological studies demonstrating high heritability of ASD, have led to many recent attempts to identify causative genetic mutations underlying the ASD phenotype. However, although hundreds of mutations have been identified to date, they are either rare variants affecting only a handful of ASD patients, or are common variants in the general population conferring only a small risk for ASD. Furthermore, the genes implicated thus far are heterogeneous in their structure and function, hampering attempts to understand shared molecular mechanisms among all ASD patients; an understanding that is crucial for the development of targeted diagnostics and therapies. However, new work is beginning to suggest that the heterogeneous set of genes implicated in ASD may ultimately converge on a few common pathways. In this review, we discuss the parallel evolution of our diagnostic and genetic understanding of autism spectrum disorders, and highlight recent attempts to infer common biology underlying this complicated syndrome.
自闭症谱系障碍(ASD)是一组异质性的神经发育综合征,其定义为言语和非言语交流受损、社交互动受限以及存在刻板行为模式。ASD的患病率正在上升,该疾病的诊断标准和临床观点也在同步不断演变。尽管大多数ASD患者没有可识别的遗传病因,但近25%的病例有可识别的致病DNA变异。由于下一代测序技术的进步,识别基因突变的能力迅速提高,再加上先前的流行病学研究表明ASD具有高度遗传性,导致最近许多人试图识别ASD表型背后的致病基因突变。然而,尽管迄今为止已识别出数百种突变,但它们要么是仅影响少数ASD患者的罕见变异,要么是普通人群中的常见变异,仅赋予ASD较小的风险。此外,迄今为止涉及的基因在结构和功能上是异质的,这阻碍了人们理解所有ASD患者之间共享的分子机制;而这种理解对于开发针对性的诊断和治疗方法至关重要。然而,新的研究开始表明,与ASD相关的异质性基因集最终可能会汇聚到一些共同的途径上。在这篇综述中,我们讨论了我们对自闭症谱系障碍的诊断和遗传学理解的平行演变,并强调了最近推断这种复杂综合征背后共同生物学机制的尝试。